BMS Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$643K Sell
5,576
-2,509
-31% -$285K 0.42% 37
2023
Q1
$860K Sell
8,085
-109
-1% -$11.8K 0.59% 29
2022
Q4
$909K Sell
8,194
-93
-1% -$9.51K 0.6% 25
2022
Q3
$714K Sell
8,287
-427
-5% -$38.1K 0.5% 34
2022
Q2
$794K Buy
8,714
+741
+9% +$65.7K 0.52% 27
2022
Q1
$654K Buy
7,973
+308
+4% +$24.3K 0.42% 46
2021
Q4
$587K Buy
+7,665
New +$611K 0.37% 55

Other funds holding MRK

BMS Financial Advisors's MRK Position: Q2 2023 in Review

BMS Financial Advisors reduced its Merck (MRK) stake by 31% in Q2 2023, selling an estimated $285K and leaving 5,576 shares worth $643K. The position accounts for 0.42% of the portfolio, ranked #37.

BMS Financial Advisors first reported a position in MRK in Q4 2021 and has held it in 7 quarters since. The position peaked at $909K in Q4 2022. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • BMS Financial Advisors held 5,576 shares of Merck worth $643K as of Q2 2023.
  • BMS Financial Advisors sold 2,509 Merck shares in Q2 2023, an estimated $285K.
  • Merck made up 0.42% of BMS Financial Advisors's portfolio in Q2 2023, its #37 holding.
  • BMS Financial Advisors first reported a position in Merck in Q4 2021 and has held it in 7 quarters since.
  • BMS Financial Advisors's Merck position peaked at $909K in Q4 2022.
  • 3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on BMS Financial Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.